End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
750,000 KRW | -1.32% | +2.74% | -1.32% |
Jun. 06 | Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe | DJ |
May. 31 | Samsung Biologics Aims to Lower Greenhouse Gas Emissions by 2030 | MT |
ETFs positioned on Samsung Biologics Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.63% | 2 M€ | -14.14% | ||
0.92% | 11 M€ | -.--% | - | |
0.43% | 15 M€ | +15.02% | ||
0.15% | 451 M€ | +6.10% | - | |
0.15% | 2,838 M€ | +8.49% | - | |
0.15% | 152 M€ | +5.71% | - | |
0.13% | 4 M€ | -4.41% | - | |
0.07% | 11 M€ | +4.31% | ||
0.05% | 114 M€ | +4.36% | - | |
0.04% | 7 M€ | +5.53% | - | |
0.02% | 36 M€ | +9.40% | - | |
0.01% | 324 M€ | +6.59% | - | |
0.01% | 40 M€ | +6.57% | - | |
0.01% | 414 M€ | +10.01% | - | |
0.01% | 104 M€ | +4.15% | - | |
0.01% | 17 M€ | +3.78% | - | |
0.01% | 55 M€ | +1.07% | - | |
0.01% | 8 M€ | +1.54% | - | |
0.00% | 7 M€ | +0.11% | - | |
0.00% | 32 M€ | +4.30% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.32% | 38.74B | |
+0.82% | 91.94B | |
-12.88% | 32.82B | |
+64.77% | 26.66B | |
-16.31% | 15.32B | |
-5.78% | 13.3B | |
-11.38% | 11.65B | |
-49.84% | 10.12B | |
+5.24% | 9.06B | |
+173.10% | 10.37B |
- Stock Market
- Equities
- A207940 Stock
- Funds and ETFs Samsung Biologics Co.,Ltd.